Fact CheckerSign in

NCT06313827Recruiting

e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population

Effectiveness of an e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population: a Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 13 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trial is to analyse the impact of a telematic assessment and monitoring protocol in people with cystic fibrosis, in order to identify exacerbations early, thus preventing loss of lung function and maintaining quality of life. Participants will be assigned to one of 3 study groups: Control group (CG-1): will receive their usual physiotherapy treatment; Treatment group (TG-2): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment; Treatment and follow-up group (TGF-3): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment, plus telematic control of exacerbations with feedback from the physiotherapist.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
1 Mar 2024
Start date
1 Oct 2024
Primary completion date
Jan 2026
Lead sponsor
University of Valencia
NCT number
NCT06313827

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 Oct 2024 to the primary completion date, Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with lung transplant or on the waiting list for lung transplantation
  • Previous eye surgery (3 months)

Other illness

  • Active infection or inflammatory process

Other

  • Hemothorax
  • Tumors
  • Cognitive problems that make it impossible for them to use telematic devices.

Who the study is looking for

  • Diagnosed cystic fibrosis
  • Family access to an internet-enabled device
  • Camera and microphone
  • Absence of exacerbations in the last 30 days

Age in the registry: 6 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Instalaciones de la Universitat de Valencia
Coordinator of this site? Confirm its status
ValenciaSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.